 BURNABY, British Columbia, May 31, 2021 GLOBE NEWSWIRE -- Xenon Pharmaceuticals Inc. Nasdaq:XENE, a clinical stage biopharmaceutical company, today announced that members of its executive management team will participate in the following investor conference: 